Creating sustainable healthcare: ensuring new diagnostics avoid harms, improve outcomes, and direct resources wisely

用于风险评估和早期检测的新型成像、生物标志物和基因组测试正在成为改变临床实践的主要力量。在为患者带来进步和新益处的同时，新技术也可能产生有害的、意想不到的后果——过度诊断和过度治疗。这个多学科的CRE将研究如何应对新兴技术，以优化健康结果，同时避免伤害和明智地指导医疗资源。

Novel imaging, biomarkers and genomic tests for risk assessment and early detection are emerging as major forces for change in clinical practice. While providing advances and new benefits for patients, new technologies can also have harmful, unintended consequences - overdiagnosis and overtreatment. This multidisciplinary CRE will investigate how to respond to emerging technologies to optimise health outcomes while avoiding harms and directing healthcare resources wisely.